GINGER YRABEDRA: Open Payments
NPI 1407417652 · CARTERSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 26 payments from 14 companies in 2025. Trend: 2023 $679 · 2024 $357 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $147 |
| Novo Nordisk Inc | 4 | $72 |
| Lilly USA, LLC | 4 | $60 |
| ABBVIE INC. | 2 | $58 |
| Exact Sciences Corporation | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Dexcom, Inc. | 1 | $29 |
| Amneal Pharmaceuticals LLC | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
Products named: Auvelity, MOUNJARO, Cologuard Collection Kit, Ozempic, CAPLYTA, UBRELVY, AIRSUPRA, Dexcom G6 Transmitter.
Industry payments across GA — which companies pay providers there.
